jakafi reach primari endpoint agvhd
patient outcom track respons cell therapi gvhd
quick read much better fear bottom-lin deliveri
analyst certif import disclosur see
jakafi reach primari endpoint agvhd
announc posit top-lin result on-going pivot open-label trial evalu jakafi combin
corticosteroid steroid-refractori acut graft-versus-host diseas agvhd studi met primari endpoint demonstr overal
respons rate orr day best orr respons time meso set day orr
fda-sanct pre-specifi hurdl pediatr agvhd common teae grade anemia thrombocytopenia
neutropenia fda breakthrough therapi design btd plan file snda jakafi treat agvhd base
look forward investor day later today discuss around agvhd result
patient outcom track respons cell therapi gvhd
thursday mesoblast announc day surviv on-going phase trial remestemcel-l cell therapi pediatr
steroid-refractori graft-versus-host diseas gvhd believ result point clear correl day respons day
surviv amongst day respond remain aliv day sharpli higher surviv rate calcul
non-respond remind day respons rate clear pre-specifi histor benchmark
sanction fda surviv data hand believ mesoblast remain track file bla remestemcel-l orphan
indic end reiter outperform rate pt
quick read much better fear bottom-lin deliveri
overal look favor upon much better expect result report kr morn contrast cautiou preview
publish last week expect comp earn shortfal bottom-lin ep easili top street forecast
subdu expect id sale ex-fuel increas slightli street forecast ahead estim
manag commentari suggest posit start restock kroger led strong cost control altern revenu stream
lift ep forecast reflect better expect expens control favor gross margin perform
pt goe
